| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/23/1997 | CA1339468C Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same |
| 09/18/1997 | WO1997034009A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 09/18/1997 | WO1997034008A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 09/18/1997 | WO1997034002A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | WO1997034001A1 Clostridium perfringens vaccines |
| 09/18/1997 | WO1997034000A1 Expression and secretion of heterologous polypeptides from caulobacter |
| 09/18/1997 | WO1997033999A1 Immunity to trypanosomatids species |
| 09/18/1997 | WO1997033912A2 Uses of gdnf and gdnf receptor |
| 09/18/1997 | WO1997033910A1 Immunomodulatory peptides of vespid antigen 5 |
| 09/18/1997 | WO1997033909A2 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer |
| 09/18/1997 | WO1997033616A1 Methods for treatment of allergic diseases with ige |
| 09/18/1997 | WO1997033615A2 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
| 09/18/1997 | WO1997033614A1 Use of coxiella bacteria to treat autoimmune disease |
| 09/18/1997 | WO1997033613A1 Parasite-derived anti-inflammatory immunomodulatory protein |
| 09/18/1997 | WO1997033612A1 Dialdehydes as immunostimulatory adjuvants and cross-linkers for producing immunogenic preparations and generating pressure and cross-link treated cells for enhancing and augmenting the immune response against cancers, tumors and pathogenic diseases |
| 09/18/1997 | WO1997033611A1 Method of killing target cells in harvested cell populations with one or more immunotoxins |
| 09/18/1997 | WO1997033610A1 DNA ENCODING 28 kDa GLUTATHIONE S-TRANSFERASE OF SCHISTOSOMA MANSONI AND USES THEREOF |
| 09/18/1997 | WO1997033606A1 PROGRAMMED CELL DEATH AND INTERLEUKIN-1$g(b) |
| 09/18/1997 | WO1997033604A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| 09/18/1997 | WO1997033602A1 Peptides with increased binding affinity for hla molecules |
| 09/18/1997 | WO1997023607A3 Presentation of antigen, introduced into cells by stimulation of macropinocytosis |
| 09/18/1997 | WO1997022695A3 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 09/18/1997 | CA2249742A1 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer |
| 09/18/1997 | CA2249007A1 Parasite-derived anti-inflammatory immunomodulatory protein |
| 09/18/1997 | CA2248978A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 09/18/1997 | CA2248707A1 Clostridium perfringens vaccines |
| 09/18/1997 | CA2248684A1 Immunity to trypanosomatids species |
| 09/18/1997 | CA2248657A1 Peptides with increased binding affinity for hla molecules |
| 09/18/1997 | CA2248620A1 Method of killing target cells in harvested cell populations with one or more immunotoxins |
| 09/18/1997 | CA2248612A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 09/18/1997 | CA2248551A1 Programmed cell death and interleukin-1.beta. |
| 09/18/1997 | CA2248537A1 Immunomodulatory peptides of vespid antigen 5 |
| 09/18/1997 | CA2248192A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| 09/18/1997 | CA2247804A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | CA2246768A1 Uses of gdnf and gdnf receptor |
| 09/18/1997 | CA2246427A1 Methods for treatment of allergic diseases with ige |
| 09/17/1997 | EP0795017A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof |
| 09/17/1997 | EP0795014A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 09/17/1997 | EP0794966A1 Humanized antibodies to cd38 |
| 09/17/1997 | EP0794797A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 09/17/1997 | EP0794792A1 Method of promoting an immune response with a bispecific antibody |
| 09/17/1997 | EP0634937B1 Vaccines containing non-ionic surfactant vesicles |
| 09/17/1997 | EP0590060B1 Orally administrable therapeutic proteins and method of making |
| 09/17/1997 | EP0537280B1 Preparation and use of transfer factor |
| 09/17/1997 | CN1159831A Vaccines containing borrelia burgdorferi OSPG |
| 09/17/1997 | CN1159830A Immunomodulators |
| 09/17/1997 | CN1159827A FLT-4 (fms-like tyrosine-kinase), FLT-15, variants thereof uses as growth factor inhibitors |
| 09/17/1997 | CN1159811A Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 09/17/1997 | CN1159761A Vaccine compositions |
| 09/17/1997 | CN1159760A Enteral vaccine for vaginal infections |
| 09/17/1997 | CN1159759A Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 09/16/1997 | US5668253 Peptide having antigenic properties similar to "a "determinant of hepatitis B surface antigen |
| 09/16/1997 | US5667979 Use of specific properties of allergens, allergens from animal or botanical sources and methods for their isolation |
| 09/16/1997 | US5667966 Mouse monoclonal antibodies to Hepatitis E virus and methods for using same |
| 09/16/1997 | US5667787 Purification of a pertussis outer membrane protein |
| 09/16/1997 | US5667786 Method for treating tumors with a toxin |
| 09/16/1997 | US5667785 Vaccine for protection of cats against feline infectious peritonitis |
| 09/16/1997 | US5667784 Tocols as adjuvant in vaccine |
| 09/16/1997 | US5667782 Multiple particulate antigen delivery system |
| 09/16/1997 | US5667781 Enhanced inhibition of tumor cell proliferation using a combination of two monoclonal antibodies to the human transferrin receptor |
| 09/16/1997 | US5667777 Gene therapy for treatment of glomerular kidney disease, expression of beta-galactosidase |
| 09/16/1997 | CA1339466C Vaccine |
| 09/12/1997 | WO1997032988A1 Adeno-associated virus vector for boosting immunogenicity of cells |
| 09/12/1997 | WO1997032983A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines |
| 09/12/1997 | WO1997032980A1 Transferrin receptor genes of moraxella |
| 09/12/1997 | WO1997032889A1 MURINE α(1,3)FUCOSYLTRANSFERASE Fuc-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 09/12/1997 | WO1997032654A1 Filtration of plasma mixtures using cellulose-based filter aids |
| 09/12/1997 | WO1997032605A1 Cytomegalovirus nucleic acids encoding proteins having normal or altered class i mhc binding and treatment of diseases |
| 09/12/1997 | WO1997032602A1 DELIVERY SYSTEM USING mAb 3E10 AND MUTANTS AND/OR FUNCTIONAL FRAGMENTS THEREOF |
| 09/12/1997 | WO1997032600A1 Peptide-base immunotherapeutic agent for allergic diseases |
| 09/12/1997 | WO1997032599A1 Chemically-modified clostridiatoxin with improved properties |
| 09/12/1997 | WO1997032598A2 Vaccines |
| 09/12/1997 | WO1997032585A1 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
| 09/12/1997 | WO1997032572A2 Materials and methods for enhancing cellular internalization |
| 09/12/1997 | WO1997032571A1 Functionalized nanotubes |
| 09/12/1997 | WO1997022698A3 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/12/1997 | CA2248233A1 Delivery system using mab 3e10 and mutants and/or functional fragments thereof |
| 09/12/1997 | CA2248095A1 Transferrin receptor genes of moraxella |
| 09/12/1997 | CA2247817A1 Filtration of plasma mixtures using cellulose-based filter aids |
| 09/12/1997 | CA2247091A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines |
| 09/12/1997 | CA2238029A1 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
| 09/11/1997 | DE19608751A1 Adeno-assoziierter Virus-Vektor zur Steigerung der Immunogenität von Zellen Adeno-associated virus vector for enhancing the immunogenicity of cells |
| 09/10/1997 | EP0794257A1 Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino aced sequence and vaccine containing same |
| 09/10/1997 | EP0793728A1 Expression of the bovine parainfluenza virus type 3 hemagglutinin/neuraminidase (hn) glycoprotein in two heterologous systems |
| 09/10/1997 | EP0793725A1 Nuclear protein serine/threonine kinases |
| 09/10/1997 | EP0793721A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 09/10/1997 | EP0793720A2 Hemoglobin receptors from neisseriae |
| 09/10/1997 | EP0793717A1 Oral immunization with transgenic plants |
| 09/10/1997 | EP0793676A1 Novel membrane proteins of helicobacter pylori |
| 09/10/1997 | EP0793675A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 09/10/1997 | EP0793510A1 Methods for use of novel lyoprotectants and instant kit formulations for radiopharmaceuticals using the same |
| 09/10/1997 | EP0793506A1 Cellular and serum protein anchors and conjugates |
| 09/10/1997 | EP0793504A1 Chimeric cytokines and uses thereof |
| 09/10/1997 | EP0793501A1 In vivo activation of tumor-specific cytotoxic t cells |
| 09/10/1997 | EP0793500A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
| 09/10/1997 | EP0793484A1 Adjuvant for a vaccine composition |
| 09/10/1997 | EP0689454B1 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| 09/10/1997 | EP0558635B1 Improved matrix metalloprotease inhibitors |
| 09/10/1997 | EP0546073B1 production and use of transgenic non-human animals capable of producing heterologous antibodies |
| 09/10/1997 | EP0485388B1 Vaccine for immunizing cats against toxoplasma oocyst shedding |